Haleon Strengthens Presence in China with £65 Million Investment in New Oral Health Manufacturing Site

Haleon, a consumer company focused on better everyday health, is investing £65 million in a new oral health manufacturing site in Shanghai. The facility will support the expansion of its oral care portfolio into China's fast-growing tier 2 and tier 3 cities. Haleon's parodontax brand, clinically proven to target the root cause of bleeding gums, is expanding across China with a multi-channel retail strategy.